Increased vulnerability to demyelination in streptozotocin diabetic rats

Pamela B. Jaffey, Benjamin Gelman

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Demyelination is a prominent feature in nerve biopsies of patients with diabetic neuropathy. The mechanism is unknown because diabetic rodents, unlike humans, do not consistently develop segmental demyelination. We examined how diabetes influences toxicant-induced demyelination, remyelination, Schwann cell nerve growth factor receptor (p75) expression, and endoneurial macrophage apolipoprotein E (apo E) synthesis in diabetic rats. Postnatal day 17 (P17) rats were given 110 mg/kg streptozotocin intraperitoneally and then fed a diet containing metallic tellurium (Te) from P20 to P27 to induce demyelination. Transverse electron micrographs and immunostained longitudinal cryosections were prepared from sciatic nerve during demyelination and remyelination. Diabetic rats had a mean serum glucose concentration of 490 mg/dl and consumed equivalent doses of peroral Te. The number of demyelinated fibers in electron micrographs was increased significantly by 17% (P < .0011). Endoneurial density of p75-stained Schwann cells was increased in diabetic rats in proportion to the increased number of injured internodes. Density of apo E- and ED1-positive macrophages also was significantly increased in diabetes. There was no delay in macrophage myelin clearance, and remyelination was not compromised. Increased Schwann cell vulnerability to stress, by increasing the turnover rate of myelinated units, may explain why myelin defects accumulate after long-standing diabetes.

Original languageEnglish (US)
Pages (from-to)55-61
Number of pages7
JournalJournal of Comparative Neurology
Volume373
Issue number1
DOIs
StatePublished - Sep 9 1996

Fingerprint

Demyelinating Diseases
Streptozocin
Schwann Cells
Tellurium
Macrophages
Apolipoproteins E
Myelin Sheath
Electrons
Nerve Growth Factor Receptor
Diabetic Neuropathies
Sciatic Nerve
Rodentia
Diet
Biopsy
Glucose
Serum

Keywords

  • diabetic neuropathy
  • macrophage
  • nerve growth factor
  • segmental demyelination
  • tellurium

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Increased vulnerability to demyelination in streptozotocin diabetic rats. / Jaffey, Pamela B.; Gelman, Benjamin.

In: Journal of Comparative Neurology, Vol. 373, No. 1, 09.09.1996, p. 55-61.

Research output: Contribution to journalArticle

Jaffey, Pamela B. ; Gelman, Benjamin. / Increased vulnerability to demyelination in streptozotocin diabetic rats. In: Journal of Comparative Neurology. 1996 ; Vol. 373, No. 1. pp. 55-61.
@article{38daa0fe83b643089da6c9a67d7cd391,
title = "Increased vulnerability to demyelination in streptozotocin diabetic rats",
abstract = "Demyelination is a prominent feature in nerve biopsies of patients with diabetic neuropathy. The mechanism is unknown because diabetic rodents, unlike humans, do not consistently develop segmental demyelination. We examined how diabetes influences toxicant-induced demyelination, remyelination, Schwann cell nerve growth factor receptor (p75) expression, and endoneurial macrophage apolipoprotein E (apo E) synthesis in diabetic rats. Postnatal day 17 (P17) rats were given 110 mg/kg streptozotocin intraperitoneally and then fed a diet containing metallic tellurium (Te) from P20 to P27 to induce demyelination. Transverse electron micrographs and immunostained longitudinal cryosections were prepared from sciatic nerve during demyelination and remyelination. Diabetic rats had a mean serum glucose concentration of 490 mg/dl and consumed equivalent doses of peroral Te. The number of demyelinated fibers in electron micrographs was increased significantly by 17{\%} (P < .0011). Endoneurial density of p75-stained Schwann cells was increased in diabetic rats in proportion to the increased number of injured internodes. Density of apo E- and ED1-positive macrophages also was significantly increased in diabetes. There was no delay in macrophage myelin clearance, and remyelination was not compromised. Increased Schwann cell vulnerability to stress, by increasing the turnover rate of myelinated units, may explain why myelin defects accumulate after long-standing diabetes.",
keywords = "diabetic neuropathy, macrophage, nerve growth factor, segmental demyelination, tellurium",
author = "Jaffey, {Pamela B.} and Benjamin Gelman",
year = "1996",
month = "9",
day = "9",
doi = "10.1002/(SICI)1096-9861(19960909)373:1<55::AID-CNE5>3.0.CO;2-C",
language = "English (US)",
volume = "373",
pages = "55--61",
journal = "Journal of Comparative Neurology",
issn = "0021-9967",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Increased vulnerability to demyelination in streptozotocin diabetic rats

AU - Jaffey, Pamela B.

AU - Gelman, Benjamin

PY - 1996/9/9

Y1 - 1996/9/9

N2 - Demyelination is a prominent feature in nerve biopsies of patients with diabetic neuropathy. The mechanism is unknown because diabetic rodents, unlike humans, do not consistently develop segmental demyelination. We examined how diabetes influences toxicant-induced demyelination, remyelination, Schwann cell nerve growth factor receptor (p75) expression, and endoneurial macrophage apolipoprotein E (apo E) synthesis in diabetic rats. Postnatal day 17 (P17) rats were given 110 mg/kg streptozotocin intraperitoneally and then fed a diet containing metallic tellurium (Te) from P20 to P27 to induce demyelination. Transverse electron micrographs and immunostained longitudinal cryosections were prepared from sciatic nerve during demyelination and remyelination. Diabetic rats had a mean serum glucose concentration of 490 mg/dl and consumed equivalent doses of peroral Te. The number of demyelinated fibers in electron micrographs was increased significantly by 17% (P < .0011). Endoneurial density of p75-stained Schwann cells was increased in diabetic rats in proportion to the increased number of injured internodes. Density of apo E- and ED1-positive macrophages also was significantly increased in diabetes. There was no delay in macrophage myelin clearance, and remyelination was not compromised. Increased Schwann cell vulnerability to stress, by increasing the turnover rate of myelinated units, may explain why myelin defects accumulate after long-standing diabetes.

AB - Demyelination is a prominent feature in nerve biopsies of patients with diabetic neuropathy. The mechanism is unknown because diabetic rodents, unlike humans, do not consistently develop segmental demyelination. We examined how diabetes influences toxicant-induced demyelination, remyelination, Schwann cell nerve growth factor receptor (p75) expression, and endoneurial macrophage apolipoprotein E (apo E) synthesis in diabetic rats. Postnatal day 17 (P17) rats were given 110 mg/kg streptozotocin intraperitoneally and then fed a diet containing metallic tellurium (Te) from P20 to P27 to induce demyelination. Transverse electron micrographs and immunostained longitudinal cryosections were prepared from sciatic nerve during demyelination and remyelination. Diabetic rats had a mean serum glucose concentration of 490 mg/dl and consumed equivalent doses of peroral Te. The number of demyelinated fibers in electron micrographs was increased significantly by 17% (P < .0011). Endoneurial density of p75-stained Schwann cells was increased in diabetic rats in proportion to the increased number of injured internodes. Density of apo E- and ED1-positive macrophages also was significantly increased in diabetes. There was no delay in macrophage myelin clearance, and remyelination was not compromised. Increased Schwann cell vulnerability to stress, by increasing the turnover rate of myelinated units, may explain why myelin defects accumulate after long-standing diabetes.

KW - diabetic neuropathy

KW - macrophage

KW - nerve growth factor

KW - segmental demyelination

KW - tellurium

UR - http://www.scopus.com/inward/record.url?scp=0029763529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029763529&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9861(19960909)373:1<55::AID-CNE5>3.0.CO;2-C

DO - 10.1002/(SICI)1096-9861(19960909)373:1<55::AID-CNE5>3.0.CO;2-C

M3 - Article

VL - 373

SP - 55

EP - 61

JO - Journal of Comparative Neurology

JF - Journal of Comparative Neurology

SN - 0021-9967

IS - 1

ER -